ProCE Banner Activity

How I Approach Potential Drug–Drug Interactions in My Patients With HIV-1 Infection Starting HCV Therapy

Conference Coverage
Clinical Thought
Managing people living with both HIV and HCV and polypharmacy can be difficult. How do you analyze which HCV regimen to use and identify relevant drug interactions?

Released: December 12, 2018

Expiration: December 11, 2019

Share

Faculty

Annie Luetkemeyer

Annie Luetkemeyer, MD

Associate Professor of Medicine
Division of HIV, ID, & Global Medicine
San Francisco General Hospital
University of California, San Francisco
San Francisco, California

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by an independent educational grant from

Gilead

Faculty Disclosure

Primary Author

Annie Luetkemeyer, MD

Associate Professor of Medicine
Division of HIV, ID, & Global Medicine
San Francisco General Hospital
University of California, San Francisco
San Francisco, California

Annie Luetkemeyer, MD, has disclosed that she has received funds for research support (paid to her institution) from AbbVie, Gilead Sciences, Merck, and Proteus.